NDC properties for "Hyrimoz Plaque Psoriasis or Uveitis Starter Kit" (RxCUI 2641671)
About this data
The tables show NDC propoerties for Hyrimoz Plaque Psoriasis or Uveitis Starter Kit with the RxCUI 2641671
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Hyrimoz Plaque Psoriasis or Uveitis Starter Kit (RxCUI 2641671)
| BLA | BLA761071 |
|---|---|
| MMSL_CODE | BD39600 |
| RxCUI | 2641671 |
| SPL_SET_ID | 1ac7d061-3380-468c-b077-c05f8dfbc829 |
| SPL_SET_ID | 3e303a4a-980b-4f2a-9d03-786928758637 |
| Prescribable Synonym | Hyrimoz Plaque Psoriasis or Uveitis Starter Kit |
| RXNAV_STR | Hyrimoz Plaque Psoriasis or Uveitis Starter Kit |
| RxNorm Name | {2 (0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]) / 1 (0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector [Hyrimoz]) } Pack [Hyrimoz Plaque Psoriasis Starter Kit] |
| RxNorm Synonym | Hyrimoz Plaque Psoriasis or Uveitis Starter Kit |
| Related queries | Interactions (for RxCUI 2641671) |
NDC Properties
NDC Item 61314051736
| NDC 9 | 61314-517 |
|---|---|
| NDC 10 | 61314-517-36 |
| NDC Item | 61314051736 |
| Packaging | 3 KIT in 1 CARTON (61314-517-36) / 1 KIT in 1 KIT * 2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE * 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-517 |
NDC Item 83457011201
| NDC 9 | 83457-112 |
|---|---|
| NDC 10 | 83457-112-01 |
| NDC Item | 83457011201 |
| Packaging | 1 KIT in 1 CARTON (83457-112-01) * 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE * 2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-112 |
NDC Item 61314051736
| NDC 9 | 61314-517 |
|---|---|
| NDC 10 | 61314-517-36 |
| NDC Item | 61314051736 |
| Packaging | 3 KIT in 1 CARTON (61314-517-36) / 1 KIT in 1 KIT * 2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE * 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782789 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 61314-517 |
NDC Item 83457011201
| NDC 9 | 83457-112 |
|---|---|
| NDC 10 | 83457-112-01 |
| NDC Item | 83457011201 |
| Packaging | 1 KIT in 1 CARTON (83457-112-01) * 1 SYRINGE in 1 CARTON / .8 mL in 1 SYRINGE * 2 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE |
| BLA | BLA761071 |
| FDA SPL set id | 782641 |
| Labeler | Cordavis Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-15 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 83457-112 |